Compare ECPG & STAA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ECPG | STAA |
|---|---|---|
| Founded | 1998 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 1999 | 1995 |
| Metric | ECPG | STAA |
|---|---|---|
| Price | $103.47 | $24.11 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 9 |
| Target Price | ★ $77.33 | $22.81 |
| AVG Volume (30 Days) | 352.5K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 287.14 | N/A |
| EPS | ★ 6.66 | 0.26 |
| Revenue | ★ $1,768,802,000.00 | $239,442,000.00 |
| Revenue This Year | $4.53 | $30.82 |
| Revenue Next Year | $4.76 | $8.41 |
| P/E Ratio | ★ $15.57 | $92.65 |
| Revenue Growth | ★ 34.37 | N/A |
| 52 Week Low | $39.95 | $15.59 |
| 52 Week High | $104.98 | $35.87 |
| Indicator | ECPG | STAA |
|---|---|---|
| Relative Strength Index (RSI) | 64.86 | 44.27 |
| Support Level | $77.69 | $22.91 |
| Resistance Level | N/A | $25.31 |
| Average True Range (ATR) | 4.07 | 1.38 |
| MACD | 0.70 | 0.30 |
| Stochastic Oscillator | 88.70 | 49.07 |
Encore Capital Group Inc is an international specialty finance company engaged in providing debt recovery solutions and other related services for consumers across a broad range of financial assets. It mainly purchases portfolios of defaulted consumer receivables at deep discounts to face value and manages them by working with individuals to repay their obligations and work toward financial recovery. The company also provides debt servicing and other portfolio management services to credit originators for non-performing loans in Europe. It has only one reportable segment, debt purchasing and recovery. Geographically, the company generates maximum revenue from its business in the United States, followed by the United Kingdom, Europe, and other regions.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.